ライフサイエンスコーパス: compared with @1 controls

1 Despite enhanced weight gain and plasma lipid levels compared with Apoe(-/-) controls, EphA2(-/-)Apoe(-/-) knockou

2 litude and frequency of postsynaptic currents were enhanced compared with controls.

3 ly improved bacterial clearance during the bacteremic stage compared with controls.

4 downregulated in treatment responsive residual tumors, when compared with controls.

5 across gray matter and white matter when MDD subjects were compared with controls.

6 rm 2 in BRAFi resistant cells restored sensitivity to BRAFi compared with controls.

7 ences were seen in primary or permanent decay (dt, DT) when compared with controls.

8 al competence were 3.9 (95% CI, 1.4-10.9) for MLPT children compared with controls.

9 ncoupling protein-2 (UCP2) in pancreas from rats with BD as compared with controls.

10 the effect allele had diminished contractile activity when compared with controls.

11 ucans or a SYK inhibitor reduced visceral hypersensitivity, compared with controls.

12 nter and found that insulitis made islets mechanically soft compared with controls.

13 ere similar for patients with lesions in DMF or mOFC/vmPFC, compared with Controls.

14 e showed improved glucose tolerance and insulin sensitivity compared with controls.

15 radial diffusivity was observed for schizophrenia patients compared with controls.

16 RGM and necroptosis, and increased release of nuclear DAMPs compared with controls.

17 leukin 6 (IL6), and epithelial STAT3 activation was reduced compared with controls.

18 VWF:Ag levels were significantly elevated in MGL1(-/-) mice compared with controls.

19 , and lower RV and left ventricular (LV) ejection fractions compared with controls.

20 ers in participants (mean [SD], 1.66 [0.41] vs 1.43 [0.15]) compared with controls (1.40 [0.26) vs 1.41 [0.12]) (group x

21 In addition, when compared with controls, aged HCM females exhibited adrenal gl

22 ls from hPR3Tg displayed enhanced survival during apoptosis compared with controls, and this may also contribute to the i

23 and four subscales from prechemotherapy to postchemotherapy compared with controls as well as from prechemotherapy to 6-m

24 Compared with controls, Ati-CB1-KO mice showed decreased body

25 t group effect showing higher tracer uptake in participants compared with controls (group effect, F = 8.0; P = .006).

26 8.4], mean difference 13.1 s, 95% CI 9.4 to 16.9; p<0.0001) compared with controls; however, the difference in mean time

27 s increased in tissue homogenates from patients with CRSwNP compared with controls, irrespective of the atopy status.

28 Mass deworming for soil-transmitted helminths compared with controls led to little to no improvement in wei

29 42.8 ng/L) and patients with AD dementia (mean, 51.0 ng/L) compared with controls (mean, 34.7 ng/L) (P < .001) and had h

30 cantly worse in mitochondrial and lipopolysaccharide groups compared with controls (mitochondrial-64 +/- 6, lipopolysacch

31 Compared with controls, monkeys with VS lesions had deficits

32 Results Compared with controls, more than twice as many intervention-

33 F:Ag) ratios were significantly increased in LoVIC patients compared with controls (P < .0001).

34 howed increased glutamate both in children with ASD and OCD compared with controls (p=0.007), but no differences between

35 Compared with controls, patients reported impairment of all a

36 Compared with controls, patients with recent STEMI exhibited

37 Global transcriptome analysis of L254F-OGT lymphoblastoids compared with controls revealed a small subset of genes that

38 mood dynamics (z = 4.55; P < .001) that was not attenuated compared with controls (z = -0.42; P = .67).

39 ogeneic HCT recipients showed significant cognitive decline compared with healthy controls.

40 5-3p (P = 0.007) and miR-4668-5p (P = 0.016) in AD patients compared with healthy controls.

41 23.29 to -10.82; P < .001) were reduced in patients with MS compared with healthy controls.

42 Glu was lower in adults with SZ compared with healthy controls and in older adults versus you

43 aller preoperative punctal diameter at 100 mum depth on OCT compared with healthy controls; this was not observed in pati

44 Compared with nontransgenic controls, neither transgenic mode

45 significant organ protection and markedly reduced mortality compared with nontreated controls (four of five animals survi

46 imensions are slightly larger in young competitive athletes compared with sedentary controls, but rarely >40 mm.

47 %, 54.76 +/- 0.67; fractional shortening %, 27.53 +/- 0.50) compared with sham controls (ejection fraction %, 73.57 +/- 0

48 PMDD, with more than half of these genes over-expressed as compared with the controls, and with significant effects for

49 ected with Cryptosporidium parvum oocysts for 6-13 days and compared with uninfected controls.

50 age of treated patients survived to 18 months of follow-up, compared with untreated controls (P < .001).